In this case-control study, both obesity and ALMI-based sarcopenia were associated with CTS, with sarcopenia showing a stronger association. These findings suggest an association between reduced muscle mass and CTS independent of BMI. Muscle mass assessment alongside BMI may help clinicians identify at-risk patients who might otherwise be overlooked by conventional obesity metrics.
Chun et al. (Wed,) studied this question.